LV12072B - CHARACTERIZATION OF 4-EDIBLE 1,4-DIHIDROPYRIDES - Google Patents
CHARACTERIZATION OF 4-EDIBLE 1,4-DIHIDROPYRIDES Download PDFInfo
- Publication number
- LV12072B LV12072B LVP-98-44A LV980044A LV12072B LV 12072 B LV12072 B LV 12072B LV 980044 A LV980044 A LV 980044A LV 12072 B LV12072 B LV 12072B
- Authority
- LV
- Latvia
- Prior art keywords
- group
- alkyl
- hydrogen
- taken
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75902691A | 1991-09-13 | 1991-09-13 | |
| US07/920,701 US5310917A (en) | 1991-09-13 | 1992-07-28 | Process for the preparation of 4-substituted-1,4-dihydropydrines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV12072A LV12072A (lv) | 1998-06-20 |
| LV12072B true LV12072B (en) | 1998-09-20 |
Family
ID=27116618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-98-44A LV12072B (en) | 1991-09-13 | 1998-03-06 | CHARACTERIZATION OF 4-EDIBLE 1,4-DIHIDROPYRIDES |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0534520B1 (zh) |
| JP (1) | JPH0751562B2 (zh) |
| CN (1) | CN1070907A (zh) |
| AT (1) | ATE150456T1 (zh) |
| AU (1) | AU654387B2 (zh) |
| CA (1) | CA2077919A1 (zh) |
| DE (1) | DE69218330T2 (zh) |
| DK (1) | DK0534520T3 (zh) |
| ES (1) | ES2101027T3 (zh) |
| GR (1) | GR3022877T3 (zh) |
| IL (1) | IL103010A (zh) |
| LV (1) | LV12072B (zh) |
| MX (1) | MX9205215A (zh) |
| NZ (1) | NZ244130A (zh) |
| WO (1) | WO1993006082A1 (zh) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4342196A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Neue 4-Phenyl-substituierte 1,4-Dihydropyridine |
| ES2193148T3 (es) | 1993-12-10 | 2003-11-01 | Bayer Ag | 1,4-dihidropiridinas sustituidas con fenilo con actividad cerebral. |
| DE4423445A1 (de) * | 1994-07-05 | 1996-01-11 | Bayer Ag | Katalysatorverfahren zur Herstellung von Nifedipin |
| US5554621A (en) * | 1995-06-07 | 1996-09-10 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
| US5668151A (en) * | 1995-06-07 | 1997-09-16 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: piperidine derivatives |
| US5977369A (en) * | 1995-12-28 | 1999-11-02 | Napp Technologies, Inc. | Process to prepare dihydropyridine and derivatives thereof |
| IT1283793B1 (it) * | 1996-08-23 | 1998-04-30 | Lusochimica Spa | Processo per la preparazione di diidropiridine |
| US5889016A (en) * | 1997-06-26 | 1999-03-30 | Bristol-Myers Squibb Company | Dihydropyrimidone derivatives as NPY antagonists |
| HUP9900353A3 (en) * | 1999-02-15 | 2002-01-28 | Egis Gyogyszergyar Nyilvanosan | Process for producing asymmetric esters of 1,4-dihydropyridine-dicarboxylic acids |
| JP2003502374A (ja) | 1999-06-21 | 2003-01-21 | ブリストルーマイヤーズ スクイブ カンパニー | Ｎｐｙ拮抗薬としてのジヒドロピラジン誘導体 |
| MXPA03005882A (es) | 2000-12-29 | 2005-04-19 | Pfizer Ltd | Derivado amida de amlodipina. |
| US6653481B2 (en) | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
| AT5874U1 (de) | 2000-12-29 | 2003-01-27 | Bioorg Bv | Pharmazeutische zubereitungen enthaltend amlodipinmaleat |
| BR0116557A (pt) | 2000-12-29 | 2003-10-28 | Pfizer Ltd | Processo, processo para fabricação de um sal de maleato de amlodipina substancialmente livre de aspartato de amlodipina, processo para purificação, maleato de amlodipina, composição farmacêutica para tratar ou prevenir angina ou hipertenção, método para tratar hipertenção, angina ou ataque cardìaco, benzeno sulfonato de amlodipina, hidrocloreto de amlodipina e uso de maleato de amlodipina substancialmente livre de aspartato de amlodipina |
| WO2002053541A1 (en) | 2000-12-29 | 2002-07-11 | Pfizer Limited | Amide derivative of amlodipine |
| GB2372036B (en) | 2000-12-29 | 2004-05-19 | Bioorg Bv | Aspartate derivative of amlodipine |
| EP1309557B9 (en) | 2000-12-29 | 2006-11-15 | Pfizer Limited | Amlodipine hemimaleate |
| EP1309556B1 (en) | 2000-12-29 | 2004-11-24 | Pfizer Limited | Amlodipine fumarate |
| US7335380B2 (en) | 2000-12-29 | 2008-02-26 | Synthon Ip Inc. | Amlodipine free base |
| GB2371862B (en) | 2000-12-29 | 2004-07-14 | Bioorg Bv | Reference standards for determining the purity or stability of amlodipine maleate and processes therefor |
| WO2010039977A2 (en) | 2008-10-01 | 2010-04-08 | Amira Pharmaceuticals, Inc. | Heteroaryl antagonists of prostaglandin d2 receptors |
| CN101613280B (zh) * | 2009-05-13 | 2012-10-17 | 合肥立方制药股份有限公司 | 非洛地平合成中间体2,3-二氯亚苄基乙酰乙酸甲酯的制备方法 |
| CN101987833B (zh) * | 2009-08-04 | 2014-07-30 | 北京利乐生制药科技有限公司 | 尼伐地平晶型及其制备方法 |
| WO2012123966A1 (en) | 2011-03-04 | 2012-09-20 | Arch Pharmalabs Limited | Process for the preparation of 4 -substituted -1, 4-dihydropyridines |
| CN102285911B (zh) * | 2011-07-12 | 2015-06-17 | 绍兴文理学院 | 非洛地平的制备方法 |
| CN102304079B (zh) * | 2011-09-29 | 2013-09-25 | 合肥立方制药股份有限公司 | 一种非洛地平环合反应液直接水析纯化方法 |
| US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
| US9394285B2 (en) | 2013-03-15 | 2016-07-19 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA863578B (en) * | 1985-06-21 | 1987-02-25 | Hoffmann La Roche | Dihydropyridine derivatives |
| US4780538A (en) * | 1986-02-12 | 1988-10-25 | Merck & Co., Inc. | Process for 1,4-dihydropyridine compounds using a titanamine catalyst |
| FR2596760B1 (fr) * | 1986-04-02 | 1988-12-09 | Sori Soc Rech Ind | Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique |
| JPH02149563A (ja) * | 1988-11-30 | 1990-06-08 | Nisshin Flour Milling Co Ltd | ２−ハロエトキシカルボニル基を含有する１，４−ジヒドロピリジン誘導体の製造法 |
| JPH04211060A (ja) * | 1990-03-07 | 1992-08-03 | Tokawa Tetsuo | ２，６−ジメチル−４−（ｍ−ニトロフェニル）−１，４−ジヒドロピリジン−３，５−ジカルボン酸−３−メチルエステル−５−β−（Ｎ−ベンジル−Ｎ−メチルアミノ）エチルエステルの新規製造方法 |
| DE4011695A1 (de) * | 1990-04-11 | 1991-10-17 | Bayer Ag | Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung |
-
1992
- 1992-08-26 WO PCT/US1992/007220 patent/WO1993006082A1/en unknown
- 1992-08-28 NZ NZ244130A patent/NZ244130A/en unknown
- 1992-09-01 IL IL10301092A patent/IL103010A/en not_active IP Right Cessation
- 1992-09-05 ES ES92202690T patent/ES2101027T3/es not_active Expired - Lifetime
- 1992-09-05 DK DK92202690.1T patent/DK0534520T3/da active
- 1992-09-05 AT AT92202690T patent/ATE150456T1/de not_active IP Right Cessation
- 1992-09-05 EP EP92202690A patent/EP0534520B1/en not_active Expired - Lifetime
- 1992-09-05 DE DE69218330T patent/DE69218330T2/de not_active Expired - Fee Related
- 1992-09-07 JP JP4238429A patent/JPH0751562B2/ja not_active Expired - Fee Related
- 1992-09-10 CA CA002077919A patent/CA2077919A1/en not_active Abandoned
- 1992-09-11 AU AU23552/92A patent/AU654387B2/en not_active Ceased
- 1992-09-11 MX MX9205215A patent/MX9205215A/es not_active IP Right Cessation
- 1992-09-11 CN CN92110385.9A patent/CN1070907A/zh active Pending
-
1997
- 1997-03-20 GR GR970400486T patent/GR3022877T3/el unknown
-
1998
- 1998-03-06 LV LVP-98-44A patent/LV12072B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0751562B2 (ja) | 1995-06-05 |
| DK0534520T3 (da) | 1997-09-08 |
| GR3022877T3 (en) | 1997-06-30 |
| WO1993006082A1 (en) | 1993-04-01 |
| ES2101027T3 (es) | 1997-07-01 |
| AU2355292A (en) | 1993-03-18 |
| LV12072A (lv) | 1998-06-20 |
| EP0534520A3 (en) | 1993-05-05 |
| CA2077919A1 (en) | 1993-03-14 |
| ATE150456T1 (de) | 1997-04-15 |
| EP0534520B1 (en) | 1997-03-19 |
| DE69218330T2 (de) | 1997-09-18 |
| DE69218330D1 (de) | 1997-04-24 |
| MX9205215A (es) | 1993-03-01 |
| IL103010A0 (en) | 1993-02-21 |
| NZ244130A (en) | 1994-10-26 |
| CN1070907A (zh) | 1993-04-14 |
| EP0534520A2 (en) | 1993-03-31 |
| JPH05221984A (ja) | 1993-08-31 |
| AU654387B2 (en) | 1994-11-03 |
| IL103010A (en) | 1996-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV12072B (en) | CHARACTERIZATION OF 4-EDIBLE 1,4-DIHIDROPYRIDES | |
| EP0126094B1 (fr) | Nouveaux esters de 1,4-dihydropyridines et leurs procedes de preparation et medicaments contenant lesdits esters | |
| IE57715B1 (en) | Asymmetrical diesters of 1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylic acid | |
| IE872706L (en) | Dihydropyridine derivatives | |
| EP1125924B1 (en) | Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization | |
| AU777565B2 (en) | Process for preparing amlodipine benzenesulphonate | |
| US5310917A (en) | Process for the preparation of 4-substituted-1,4-dihydropydrines | |
| CA2425561C (en) | Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof | |
| KR100646670B1 (ko) | 레르카니디핀 염화수소의 개선된 제조방법 | |
| US5977369A (en) | Process to prepare dihydropyridine and derivatives thereof | |
| FI83641C (fi) | Foerfarande foer framstaellning av 2(n-bensyl-n-metylamino)-etylmetyl-2,6-dimetyl-4-(m-nitrofenyl) -1,4-dihydropyridin-3,5-dikarboxylat och dess hydrokloridsalt. | |
| Valenti et al. | Coumarin 1, 4-dihydropyridine derivatives | |
| KR930001404B1 (ko) | 디아릴 화합물의 제조방법 | |
| JP2664941B2 (ja) | １，４―ジヒドロピリジン化合物 | |
| HUT52054A (en) | Process for producing basic nitrophenyl-dihydropyridin-amides from new intermediates and process for producing pharmaceutical compositions containing them | |
| JPH0155268B2 (zh) | ||
| KR100559800B1 (ko) | 메틸1,1,질소-트리메틸-(3,3-디페닐프로필)-2-아미노에틸-1,4-디하이드로-2,6-디메틸-4(3-니트로페닐)-피리딘-3,5-디카르복실레이트 하이드로클로라이드의 새로운 제조방법 | |
| US4634712A (en) | Antihypertensive esters of 1,4-dihydro-2,6-dimethyl-3-(alkoxycarbonyl or alkoxyalkoxycarbonyl)-4-(substituted phenyl)-pyridine-5-carboxylic acid | |
| EP0079740B1 (en) | Anthraniloyloxyalkanoates | |
| KR100811497B1 (ko) | 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법 | |
| JPH0527624B2 (zh) | ||
| JPH0253774A (ja) | １，４―ジヒドロピリジン―スレオニン誘導体 | |
| RU2146672C1 (ru) | Способ получения 3-этил-5-метил(±)2[2-аминоэтокси)-метил]-4-(2-хлорфенил)-1,4-дигидро- 6-метил-3,5-пиридиндикарбоксилат монобензолсульфоната | |
| JPH07126251A (ja) | １、４−ジヒドロピリジンモノカルボン酸類の製造方法 | |
| PL156170B1 (pl) | Sposób wytwarzania pochodnych 2-/aminoalkilotio/metylol,4-dihydropirydyny PL PL PL |